Acquired by PharmaSite Research has been acquired by Headlands Research, expanding its access to a multinational network of clinical trial sites, presenting a cross-sell opportunity for contract research services and site onboarding partnerships.

Mental Health Focus Specialization in CNS disorders and mental illness positions the company to partner on CNS-focused trials, enabling targeted outreach to sponsors seeking CNS and behavioral health studies.

Mid-sized Capacity With 11-50 employees, PharmaSite is a mid-sized site that could scale with additional study types or regional multi-site collaborations within Headlands’ network, offering a balance of agility and capacity for pilot trials.

Regional Footprint Located in Baltimore metro area with existing clinical research infrastructure, there is potential to expand site activation in nearby markets, leveraging Headlands' global footprint for faster study start-ups.

Financial Scale Reported revenue in the mid range of 10M–25M suggests viable partner for price-consolidation discussions, bundled services, or exclusive study opportunities within a networked platform.